Chromatographia

, Volume 77, Issue 7–8, pp 581–589 | Cite as

A Stability-Indicating HPLC Method for the Determination of Nitrosylcobalamin (NO-Cbl), a Novel Vitamin B12 Analog

  • Michael J. Dunphy
  • Annette M. Sysel
  • Joseph A. Lupica
  • Kristie Griffith
  • Taylor Sherrod
  • Joseph A. Bauer
Original

Abstract

Nitrosylcobalamin (NO-Cbl), a novel vitamin B12 analog and anti-tumor agent, functions as a biologic ‘Trojan horse’, utilizing the vitamin B12 transcobalamin II transport protein and cell surface receptor to specifically target cancer cells. A stability-indicating HPLC method was developed for the detection of NO-Cbl during forced degradation studies. This method utilized an Ascentis® RP-Amide (150 mm × 4.6 mm, 5 μm) column at 35 °C with a mobile phase (1.0 mL min−1) combining a gradient of methanol and an acetate buffer at pH 6.0. Detection wavelengths of 450 and 254 nm were used to detect corrin and non-corrin-based products, respectively. NO-Cbl, synthesized from hydroxocobalamin and pure nitric oxide gas, was subjected to degradative stress conditions including oxidation, hydrolysis and thermal and radiant energy challenge. The method was validated by assessing linearity, accuracy, precision, detection and quantitation limits and robustness. The method was applied successfully for purity assessment of synthesized NO-Cbl and for the determination of NO-Cbl during kinetic studies in aqueous solution and in solid-state degradation assessments. This HPLC method is suitable for the separation of cobalamins in aqueous and methanolic solutions, for routine detection of NO-Cbl and for purity assessment of synthesized NO-Cbl. Additionally, this method has potential application in identification and monitoring of diseases involving altered nitric oxide homeostasis where vitamin B12 therapy is utilized to scavenge excess nitric oxide, subsequently resulting in the in vivo production of NO-Cbl.

Keywords

Column liquid chromatography Stability-indicating method Nitrosylcobalamin Vitamin B12 Nitric oxide 

References

  1. 1.
    Rickes EL, Brink NG, Koniuszy FR, Wood TR, Folkers K (1948) Science 107:396–397CrossRefGoogle Scholar
  2. 2.
    Seetharam B, Bose S, Li N (1999) J Nutr 129(10):1761–1764Google Scholar
  3. 3.
    Expert Group on Vitamins and Minerals Secretariat (2000) Covering note for EVM/00/20/P – review of vitamin B12, pp 1–58Google Scholar
  4. 4.
    Randaccio L, Geremia S, Demitri N, Wuerges J (2010) Molecules 15(5):3228–3259CrossRefGoogle Scholar
  5. 5.
    van der Kuy PH, Merkus FW, Lohman JJ, ter Berg JW, Hooymans PM (2002) Cephalalgia 22(7):513–519CrossRefGoogle Scholar
  6. 6.
    Gerth K, Ehring T, Braendle M, Schelling P (2006) Clin Toxicol 44(Suppl 1):29–36CrossRefGoogle Scholar
  7. 7.
    Hussain SP, He P, Subleski J, Hofseth LJ, Trivers GE, Mechanic L, Hofseth AB, Bernard M, Schwank J, Nguyen G, Mathe E, Djurickovic D, Haines D, Weiss J, Back T, Gruys E, Laubach VE, Wiltrout RH, Harris CC (2008) Cancer Res 68(17):7130–7136CrossRefGoogle Scholar
  8. 8.
    Sanuphan A, Chunhacha P, Pongrakhananon V, Chanvorachote P (2013) Biomed Res Int 2013:186972CrossRefGoogle Scholar
  9. 9.
    Ashutosh K (2000) Curr Opin Pulm Med 6(1):21–25CrossRefGoogle Scholar
  10. 10.
    Chien JW, Lin CY, Yang KD, Lin CH, Kao JK, Tsai YG (2013) Clin Exp Allergy 43(9):1018–1026CrossRefGoogle Scholar
  11. 11.
    Sweeten TL, Posey DJ, Shankar S, McDougle CJ (2004) Biol Psychiat 55(4):434–437CrossRefGoogle Scholar
  12. 12.
    Tostes MH, Teixeira HC, Gattaz WF, Brandao MA, Raposo NR (2012) Pharmacopsychiatry 45(6):241–243CrossRefGoogle Scholar
  13. 13.
    Kaczka EA, Wolf DE, Kuehl FA Jr, Folkers K (1951) Biophys Acta 73:3569–3573Google Scholar
  14. 14.
    McLean GR, Pathare PM, Wilbur DS, Morgan AC, Woodhouse CS, Schrader JW, Ziltener HJ (1997) Cancer Res 57(18):4015–4022Google Scholar
  15. 15.
    Gupta Y, Kohli DV, Jain SK (2008) Crit Rev Ther Drug 25(4):347–379CrossRefGoogle Scholar
  16. 16.
    Allis DG, Fairchild TJ, Doyle RP (2010) Mol BioSyst 6(9):1611–1618CrossRefGoogle Scholar
  17. 17.
    Bauer JA (1998) Anticancer Drugs 9(3):239–244CrossRefGoogle Scholar
  18. 18.
    Bauer JA, Morrison BH, Grane RW, Jacobs BS, Dabney S, Gamero AM, Carnevale KA, Smith DJ, Drazba J, Seetharam B, Lindner DJ (2002) J Natl Cancer Inst 94(13):1010–1019CrossRefGoogle Scholar
  19. 19.
    Chawla-Sarkar M, Bauer JA, Lupica JA, Morrison BH, Tang Z, Oates RK, Almasan A, DiDonato JA, Borden EC, Lindner DJ (2003) J Biol Chem 278(41):39461–39469CrossRefGoogle Scholar
  20. 20.
    Bauer JA, Lupica JA, Schmidt H, Morrison BH, Haney RM, Masci RK, Lee RM, Didonato JA, Lindner DJ (2007) PLoS ONE 2(12):e1313CrossRefGoogle Scholar
  21. 21.
    Bauer JA, Frye G, Bahr A, Gieg J, Brofman P (2010) Invest New Drugs 28(5):694–702CrossRefGoogle Scholar
  22. 22.
    Frenkel EP, Kitchens RL, Prough R (1979) J Chromatogr 174(2):393–400CrossRefGoogle Scholar
  23. 23.
    Lee DS, Griffiths BW (1985) Clin Biochem 18(5):261–266CrossRefGoogle Scholar
  24. 24.
    Kelly RJ, Gruner TM, Sykes AR (2005) Biomed Chromatogr 19(4):329–333CrossRefGoogle Scholar
  25. 25.
    Hardlei TF, Nexo E (2009) Clin Chem 55(5):1002–1010CrossRefGoogle Scholar
  26. 26.
    Lebiedzinska A, Marszall ML, Kuta J, Szefer P (2007) J Chromatogr A 1173(1–2):71–80CrossRefGoogle Scholar
  27. 27.
    Schwertner HA, Valtier S, Bebarta VS (2012) J Chromatogr B 905:10–16CrossRefGoogle Scholar
  28. 28.
    Marley EC, Mackay E, Young G (2009) Food Addit Contam A 26(3):282–288CrossRefGoogle Scholar
  29. 29.
    Brasch NE, Finke RG (1999) J Inorg Biochem 73(4):215–219CrossRefGoogle Scholar
  30. 30.
    Blessy M, Patel RD, Prajapati PN, Agrawal YK (2013) J Pharm Anal (in press)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Michael J. Dunphy
    • 1
    • 2
  • Annette M. Sysel
    • 1
  • Joseph A. Lupica
    • 1
    • 2
  • Kristie Griffith
    • 2
  • Taylor Sherrod
    • 2
  • Joseph A. Bauer
    • 1
  1. 1.BNOAT Oncology, Inc.AkronUSA
  2. 2.Walsh UniversityNorth CantonUSA

Personalised recommendations